Josef Prchal is a Hematologist and an Oncologist in Salt Lake City, Utah. Dr. Prchal is rated as an Advanced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis, Myeloproliferative Neoplasms (MPN), and Bone Marrow Transplant. Dr. Prchal is currently accepting new patients.

Dr. Pulsipher is currently the Division Chief of the Pediatric Hematology at Intermountain Primary Children's Hospital and Oncology, Director of the Children's and Adolescent Cancer Initiative at Huntsman Cancer Institute and a Presidential Chair in Pediatric Oncology and Hematology at the University of Utah. �Dr. Pulsipher is an internationally recognized expert in Bone Marrow Transplantation and Cellular Therapy, having directed the world's largest pediatric transplant research group for more than a decade (Pediatric Transplantation and Cellular Therapy Consortium). �He has run more than 20 multicenter trials in the field and is considered and expert in broad areas of transplantation and cellular therapy. �Areas of focus have included development of reduced toxicity approaches to transplantation of both malignant and non-malignant disorders with a focus on minimizing short and long-term effects of transplant. �For non-malignant disorders he has run national protocols that have improved safety for patients with immunodeficiencies, HLH, and bone marrow failure. For cancer, he has developed techniques allowing identification of patients who can avoid radiation-based treatments for leukemia. �This has included a novel approach to safer transplantation of patients using half-matched family donors (haploidentical donors) using a novel form of bone marrow graft engineering called alpha-beta T-cell depletion. �His desire to develop safer approaches has become a major focus as he has led major studies in the field of chimeric antigen receptor T-cells (CAR T-cells), a safer approach to cancer cure. �Dr. Pulsipher's work in cell therapy helped lead to the FDA approval of the first CART cell treatment, tisagenlecleucel, and he continues to run trials in CAR T, NK, and Viral Specific T-cell therapies. He has open protocols aimed at improving outcomes and his lab efforts are focused on making CAR T-cells that last longer and avoid overcome resistance by cancer cells. Dr. Pulsipher's interests have included ensuring that the families of those undergoing transplantation and cell therapy are psychologically well throughout the process. �To help with this, he has run several large trials assessing the safety and Quality of Life of pediatric bone marrow donors and is he currently running a large national trial looking at the psychological well-being of donor and recipient families as they go through the transplant process.For questions regarding Dr. Pulsipher's adult practice at the Huntsman Cancer Institute, or for questions about any of our clinical programs and for assistance identifying the right Hematology specialist for you or your family member, please contact our Clinical Care Specialist/New Patient Coordinator at (801) 587-4652. For questions regarding Dr. Pulsipher's pediatric practice and the Blood and Marrow Transplant Program at Primary Children's Medical Center, please call (801) 662-4830. Dr. Pulsipher is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Graft Versus Host Disease (GvHD), Leukemia, Severe Combined Immunodeficiency (SCID), and Bone Marrow Transplant.

Nicholas Whipple is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Whipple is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Glioma, Anemia, Sickle Cell Disease, and Hemolytic Anemia.

Ming Lim is a Hematologist Oncology specialist and a Hematologist in Salt Lake City, Utah. Dr. Lim is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Blood Clots, Hemophilia A, Thrombocytopenia, Von Willebrand Disease (VWD), and Bone Marrow Aspiration. Dr. Lim is currently accepting new patients.

George Rodgers is a Hematologist and an Oncologist in Salt Lake City, Utah. Dr. Rodgers is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Von Willebrand Disease (VWD), Hemophilia B, Heyde Syndrome, Hereditary Hemorrhagic Telangiectasia, and Bone Marrow Aspiration. Dr. Rodgers is currently accepting new patients.

Narendranath Epperla is a Hematologist in Salt Lake City, Utah. Dr. Epperla is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma (MCL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Epperla is currently accepting new patients.

William Stephenson is a Hematologist Oncology provider in Provo, Utah. Dr. Stephenson has been practicing medicine for over 35 years and is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Drug-Induced Thrombocytopenia, Thrombocytopenia, Hemochromatosis, and Richter Syndrome. Dr. Stephenson is currently accepting new patients.

Dr. McNeer is a Professor of Clinical Pediatrics at the University of Utah School of Medicine in the Division of Pediatric Hematology/Oncology and is the Medical Director for Pediatric Hematology/Oncology at Primary Children's Hospital. She is a member of the Leukemia and Lymphoma team at the University of Utah and Primary Children's Hospital.After receiving her medical degree from New York University School of Medicine, Dr. McNeer completed her residency at Children's Memorial Hospital (now Lurie Children's Hospital), which is affiliated with Northwestern University Feinberg School of Medicine. She then completed her fellowship in Pediatric Hematology/Oncology/Stem Cell Transplant at Children's Memorial Hospital, and during her fellowship earned a master's degree in clinical investigation at Northwestern University Feinberg School of Medicine.Dr. McNeer is board-certified in Pediatrics and Pediatric Hematology and Oncology. She has authored over 25 peer-reviewed journal articles and 4 book chapters. Dr. McNeer has been an invited speaker at many national and international conferences and symposiums. She is a member of the American Society of Clinical Oncology, American Society of Hematology, as well as the American Society of Pediatric Hematology/Oncology and the Children's Oncology Group.Dr. McNeer's clinical expertise is in the treatment of children, adolescents, and young adults with hematologic malignancies such as leukemia and lymphoma, in particular those with high-risk and relapsed/refractory acute lymphoblastic leukemia. She has a leadership role within the Children's Oncology Group Acute Lymphoblastic Leukemia committee, and partners with colleagues in adult oncology to collaborate in developing treatment protocols and clinical trials for young adults with leukemia. Her research focus is on the design and implementation of clinical trials for patients with hematologic malignancies.Dr. McNeer is invested in improving overall treatment outcomes for children, adolescents, and young adults, while tailoring therapy and supportive care to individual patients in order to minimize toxicity and optimize quality of life. Dr. Mcneer is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Febrile Neutropenia, Infantile Neutropenia, and Bone Marrow Aspiration.

Dr. Pyper is currently an assistant professor at the University of Utah School of Medicine in the division of Pediatric Hematology/Oncology. He is a member of the Hematology team at the University of Utah and Primary Children's Hospital. He received his medical degree from Northwestern University Feinberg School of Medicine.Dr. Pyper completed his residency at the University of Vermont College of Medicine, University of Vermont Children's Hospital (Pediatrics). He completed his fellowship in Pediatric Hematology, Oncology and Bone Marrow Transplantation at the University of Minnesota Medical School, University of Minnesota Masonic Children's Hospital.Dr. Pyper is board-certified in Pediatrics and Pediatric Hematology and Oncology. He is a member of many professional societies, including The American Society of Pediatric Hematology/Oncology, The American Society for Hematology and the American Society for Transplantation and Cellular Therapy. He has many years teaching experience and has previously been awarded teacher of the year by the associated pediatric residency program. He also takes great interest in patient and family education to make sure that patients and families understand their medical issues in an age-appropriate way so that they are able to participate in decision-making and advocate well for themselves and their loved ones.Dr. Pyper's clinical interests include the treatment of pediatric disorders including non-malignant hematology, disorders of hemostasis and thrombosis, sickle cell disease, red cell membrane defects and hemoglobinopathies as well as bone marrow failure syndromes.His primary research interests include congenital and acquired risk factors for abnormal bleeding and clotting in pediatric patients as well as improving access to needed health care resources for high-risk pediatric patients affected by hematologic diseases. Dr. Pyper is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Hereditary Spherocytosis, Hemolytic Anemia, Acute Lymphoblastic Leukemia (ALL), and Congenital Hemolytic Anemia.

David Warner is a Hematologist Oncology provider in Murray, Utah. Dr. Warner has been practicing medicine for over 11 years and is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Dehydration, Febrile Neutropenia, Agranulocytosis, and Chronic Familial Neutropenia. Dr. Warner is currently accepting new patients.

Lauren Lee is a Hematologist Oncology specialist and a Hematologist in Salt Lake City, Utah. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Hemolytic Transfusion Reaction, Hemolysis, Sickle Cell Disease, Hemoglobinopathy, and Bone Marrow Transplant. Dr. Lee is currently accepting new patients.

Jason Stinnett is a Hematologist Oncology provider in Layton, Utah. Dr. Stinnett has been practicing medicine for over 27 years and is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Pleuropulmonary Blastoma, and Polycythemia Vera. Dr. Stinnett is currently accepting new patients.

Amandeep Godara is a Hematologist Oncology specialist and a Hematologist in Salt Lake City, Utah. Dr. Godara is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Primary Amyloidosis, Multiple Myeloma, Burkitt Lymphoma, Laminectomy, and Bone Marrow Aspiration. Dr. Godara is currently accepting new patients.

Caitlin Henry is a primary care provider, practicing in Family Medicine in Salt Lake City, Utah. Dr. Henry is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. Her top area of expertise is Sickle Cell Disease.

Sumaiya Islam is a primary care provider, practicing in Internal Medicine in Salt Lake City, Utah. Dr. Islam is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Low Sodium Level, Stroke, Acute Pancreatitis, and Sepsis. Dr. Islam is currently accepting new patients.